Lodo Therapeutics Acquires Conifer Point Pharmaceuticals prn.to/2Dxb99f

Incubators/ Accelerators to hear from at the NYC Builds Bio+ Virtual Symposium include: IndieBio , Endless Frontier Labs , Biolabs@NYULangone , Harlem Biospace , SUNY Downstate, Center for Biotech , Accelerator Life Science Partners and Mount Sinai Innovation Partners ! Register today: eventbrite.com/e/life-science…

Lodo Therapeutics Achieves Second Preclinical Milestone In Its Strategic Collaboration With Genentech prn.to/3jBj5VY

Check out "October Riverside Chats: Speaker Series with Accelerator CEO: Thong Q. Le" eventbrite.com/e/october-rive… via Eventbrite

Accelerator is attending Third Annual OHSU Startup Symposium conta.cc/1uClNvq #constantcontact

Join Accelerator's CEO Thong Le for a conversation about accelerating life science companies in NYC @ Riverside Chats eventbrite.com/e/october-rive…

Join Accelerator in Chicago at "CATTEC VII Catalyzing Tech Transfer and Startup Finance" cattecvii.eventbrite.com/?aff=estw via Eventbrite

Join Accelerator's David M. Schubert at "Who Needs a Biotech VC, Anyway?" eventbrite.com/e/who-needs-a-… via Eventbrite

Xconomy Xchange: New York's Life Science Disruptors | Xconomy xconomy.com/new-york/2015/… via Xconomy

Our CEO Thong Le explores NY's Life Science Disruptors with Regeneron Founder G. Yancopoulos March 12 #xcondisrupt tinyurl.com/pcgbdfa

WBBA's VIP Forum: Featuring AbbVie | Plenary Session & Networking | March 25 | 10:00 AM - Noon | OPEN TO ALL washbio.site-ym.com/events/event_d…

Join Petra Pharma and Lodo Therapeutics at New York's Life Science Disruptors on March 29! Register: bit.ly/nydisrupt16. #xcondisrupt

Join an exciting new team in drug development at Petra Pharma Corporation linkedin.com/jobs2/view/188…

Lodo Therapeutics is hiring: come work for a 1 of the Top 10 Start-Ups to Watch according to C&E News. linkedin.com/jobs2/view/236…

"Got Dirt?...we are seeking soil samples." linkedin.com/pulse/got-dirt… on LinkedIn

Regenerative biotech Rodeo gains WuXi, Lilly, AbbVie backing fiercebiotech.com/biotech/regene…

Proniras Corp. launches in Seattle, scores $89.5 million contract to develop new seizure drug geekwire.com/2018/proniras-… via GeekWire